Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,036 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antithrombin lowering in hemophilia: a closer look at fitusiran.
Young G, Lenting PJ, Croteau SE, Nolan B, Srivastava A. Young G, et al. Among authors: srivastava a. Res Pract Thromb Haemost. 2023 May 16;7(4):100179. doi: 10.1016/j.rpth.2023.100179. eCollection 2023 May. Res Pract Thromb Haemost. 2023. PMID: 37358958 Free PMC article. Review.
Molecular mechanisms underlying hemophilia A phenotype in seven females.
Pavlova A, Brondke H, Müsebeck J, Pollmann H, Srivastava A, Oldenburg J. Pavlova A, et al. Among authors: srivastava a. J Thromb Haemost. 2009 Jun;7(6):976-82. doi: 10.1111/j.1538-7836.2009.03346.x. Epub 2009 Mar 19. J Thromb Haemost. 2009. PMID: 19302446 Free article.
Lower-dose emicizumab prophylaxis: can less be more?
Srivastava A, Iorio A. Srivastava A, et al. J Thromb Haemost. 2024 Apr;22(4):922-925. doi: 10.1016/j.jtha.2024.01.018. J Thromb Haemost. 2024. PMID: 38521578 No abstract available.
Gene therapy for hemophilia?
Srivastava A. Srivastava A. J Thromb Haemost. 2005 Jun;3(6):1313. doi: 10.1111/j.1538-7836.2005.01407.x. J Thromb Haemost. 2005. PMID: 15946223 Free article. No abstract available.
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy.
Miesbach W, Konkle B, Chowdary P, Kaczmarek R, Leebeek F, Mahlangu J, Makris M, Pipe SW, Srivastava A, Voorberg J, Pierce GF, Peyvandi F. Miesbach W, et al. Among authors: srivastava a. J Thromb Haemost. 2024 May;22(5):1510-1515. doi: 10.1016/j.jtha.2023.12.039. Epub 2024 Jan 18. J Thromb Haemost. 2024. PMID: 38242208
Biallelic variants in CSMD1 are implicated in a neurodevelopmental disorder with intellectual disability and variable cortical malformations.
Werren EA, Peirent ER, Jantti H, Guxholli A, Srivastava KR, Orenstein N, Narayanan V, Wiszniewski W, Dawidziuk M, Gawlinski P, Umair M, Khan A, Khan SN, Geneviève D, Lehalle D, van Gassen KLI, Giltay JC, Oegema R, van Jaarsveld RH, Rafiullah R, Rappold GA, Rabin R, Pappas JG, Wheeler MM, Bamshad MJ, Tsan YC, Johnson MB, Keegan CE, Srivastava A, Bielas SL. Werren EA, et al. Among authors: srivastava a. Cell Death Dis. 2024 May 30;15(5):379. doi: 10.1038/s41419-024-06768-6. Cell Death Dis. 2024. PMID: 38816421
An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation.
Srivastava A, Ahmad R, Yadav K, Siddiqui S, Trivedi A, Misra A, Mehrotra S, Ahmad B, Ali Khan M. Srivastava A, et al. Int Immunopharmacol. 2024 May 29;136:112232. doi: 10.1016/j.intimp.2024.112232. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38815352 Review.
7,036 results